<qa>  What is the standard dose of lanreotide Autogel 120 mg every 28This study aims to explore the efficacy and safety of lanreotide Autogel 120 mg administered every 14 days in subjects with grade 1 or 2, metastatic or locally advanced, unresectable pancreatic or intestinal neuroendocrine tumours NETs once they have progressed on the standard dose of lanreotide Autogel 120 mg every 28 days. 